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Abstract 
Chronic wounds are a major health concern and they affect the lives of more than 
25 million people in the United States. They are susceptible to infection and are the 
leading cause of nontraumatic limb amputations worldwide. The wound environ-
ment is dynamic, but their healing rate can be enhanced by administration of ther-
apies at the right time. This approach requires real-time monitoring of the wound 
environment with on-demand drug delivery in a closed-loop manner. In this paper, 
a smart and automated flexible wound dressing with temperature and pH sensors 
integrated onto flexible bandages that monitor wound status in real-time to address 
this unmet medical need is presented. Moreover, a stimuli-responsive drug releas-
ing system comprising of a hydrogel loaded with thermo-responsive drug carriers 
and an electronically controlled flexible heater is also integrated into the wound 
dressing to release the drugs on-demand. The dressing is equipped with a micro-
controller to process the data measured by the sensors and to program the drug re-
lease protocol for individualized treatment. This flexible smart wound dressing has 
the potential to significantly impact the treatment of chronic wounds. 
Keywords: automated systems, flexible electronics, on-demand drug delivery sys-
tems, pH sensors, smart bandages, wound healing  
1. Introduction 
Dermal injuries can render the human body significantly vulnerable to infec-
tions.1 Skin possesses excellent regeneration properties that allow its rapid 
healing upon its injury.2 However, some traumatic injuries that cause signif-
icant skin damage such as burns or underlying conditions such as diabetes 
can overwhelm the regenerative capacity of skin.3 In such wounds, the nor-
mal healing steps of inflammation, proliferation, and maturation do not oc-
cur as expected. For example, in diabetic patients endothelial cells do not 
respond properly to the released cytokines and cannot support rapid an-
giogenesis.4 The low oxygen content reduces the ability of immune cells to 
fight environmental pathogens and thus these wound ulcers become quickly 
nonhealing.5 Studies show that over 90% of wound ulcers that were slow to 
heal or recurred after clinical discharge were infected with bacteria such as 
Staphylococcus aureus.6 The lack of proper immune response can lead to bac-
teremia and sepsis if the local infection is not treated effectively.7 As a result, 
chronic wounds are one of the key causes of limb amputations. 
The effective protection of the body against bacterial infection requires 
a combinatorial method that can: (i) rapidly cover the wound and form a 
barrier against environmental pathogens and (ii) prevent systemic infec-
tion by its early stage detection followed by localized or systemic treat-
ment with antibiotics. Existing dressings cover the wound bed and in some 
cases release therapeutic molecules passively. However, these wound dress-
ings provide limited information about the status of the healing process 
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and operate in an open loop manner. Infection is a key challenge associ-
ated with chronic wounds, and patients should either be hospitalized or be 
continuously screened by medical professionals for signs of infection add-
ing to treatment cost.7,8 Smart systems that can monitor the wound envi-
ronment without the need for dressing replacement and visits to medical 
facilities are extremely beneficial.9 The emergence of flexible electronics has 
advanced the state-of-the-art of wearable smart biomedical devices for dis-
ease diagnosis and treatment.10 Different sensors and actuators can be in-
tegrated into a single platform capable of maintaining conformal contact 
with skin.10b–d,11 Despite these advancements, wound dressings are still prim-
itive and cannot provide information about the wound status. The use of 
flexible sensors for measuring various parameters provides invaluable in-
formation helping with the selection of treatment strategy.12 For example, 
one could monitor the pH of the wound environment, which is a strong in-
dicator of bacterial infections.13 The pH of normal healing wounds is in the 
range of 5.5–6.5 during the healing phase. However, in nonhealing infected 
wounds, pH will be above 6.5.13a,14 Although blood pH can also be slightly 
affected by diet and diseases, the variations of wound pH in response to in-
fection are more severe. Thus, monitoring pH could provide important data 
on possible infection. 
Moreover, advanced medical patches can deliver therapeutics in re-
sponse to the wound status in a more controlled fashion than what is pos-
sible today. Current infection therapies often require oral (systemic) and top-
ical (e.g., on the entire wound) antibiotic administration, which need much 
larger dosage than would be required if administered locally (e.g., only in 
wound regions which need it). Such routes of antibiotic administration can 
also have several side effects on healthy tissues or organs. A local delivery 
patch, however, would overcome these drawbacks to provide more precise 
and controlled administration of therapeutics within the wound region to 
promote optimal wound healing. pH-responsive materials which function 
through a change in their ionization and thus the polymer state have been 
used for engineering self-responding drug delivery tools that can automat-
ically release their payload.15 However, the release rate of the encapsulated 
antibiotics usually depends on the environment pH and might not be suf-
ficient to remove the pathogens and create resistance. Their critical pH is 
also not easy-to-adjust, which limit their application for treatment of differ-
ent wounds. Thus, systems that benefit from a separate stimulus for drug 
release might be easier to use. 
As a demonstration of the potential for integrated wound monitoring 
and treatment using emerging flexible bioelectronics, we have engineered 
a platform capable of in situ detection of bacterial infection by continuously 
monitoring wound pH, as well as administration of antibiotics locally and 
on demand. The electronics feature an on-board wireless transceiver that 
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transmits sensor data and can receive instructions for programmed drug re-
lease; such wireless communication capabilities serve not only to improve 
healing but also to maintain remote engagement among physicians, care-
givers, and patients throughout the wound care process. 
2. Results and Discussions 
A smart bandage was engineered with multiple components including: (i) 
sensors (pH and temperature), (ii) microheater, (iii) thermo-responsive drug 
carriers embedded in a hydrogel patch, and (iv) wireless electronics to read 
the data from the sensors and to trigger and control the thermal actuation 
system if required (Figure 1). pH is among the key parameters for monitor-
ing of chronic wounds. pH of a chronic wound changes from acidic to alka-
line, which is typically interpreted as an indication of the bacterial infection.16 
Thus, it could be used for prescreening of chronic wounds. Additionally, the 
temperature sensor was utilized to provide further information about the 
wound inflammation. Thermo-responsive drug carriers were employed for 
Figure 1. Schematic and conceptual view of the automated smart bandage. The bandage was 
comprised of an array of flexible pH sensors and a flexible heater to trigger thermo-respon-
sive drug carriers containing antibiotics. Thermo-responsive drug carriers were embedded in 
a layer of alginate hydrogel which was cast around the pH sensors and on top of the flexible 
heater. The sensors and heater were connected to an electronic module that could record the 
sensors signal and power the heater if needed. The electronic module could also communi-
cate wirelessly to computers and smartphones  
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on-demand release in response to temperature variation. For this reason, 
PNIPAM-based particles were fabricated and embedded within an alginate 
hydrogel sheet. The patch was directly cast on top of a flexible heater, which 
in turn was controlled using the integrated microcontroller. The entire con-
struct was attached to a transparent medical tape to form a wearable plat-
form that was less than 3 mm thick. The platform was engineered in a way 
that the sensing modules and the integrated heater were low-cost and could 
be disposed, while the electronics could be reused. 
Potentiometric pH sensors were designed and fabricated as described in 
the Experimental Section.17 Carbon/polyaniline (PANI) and silver/silver chlo-
ride served as working and reference electrodes, respectively, and PANI was 
employed as a positive exchange membrane (Figure 2 A–C). The principle 
of operation involves protonation and deprotonation of working electrode 
in an acid and basic environment, where charge accumulation resulted in a 
voltage output that could be measured for determination of pH. 
The sensor function was evaluated in terms of stability and repeatabil-
ity over a wide range of pH values (from 4 to 10 and back to 4). The sensors 
were sequentially placed in solutions containing Na+ (142 mmol) and Ca2+ 
(2.5 mmol) with an ionic composition similar to human exudate with differ-
ent levels of pH and the generated potential between the working and ref-
erence electrodes was measured (Figure 2D). The potential measurement 
of the sensor at each pH solution was recorded after reaching equilibrium 
state and output stability was obtained. The sensors exhibited a relatively 
linear response (r2 = 0.946) with average sensitivity of −50 mV pH−1. To eval-
uate stability, sensors were immersed in the highest and lowest physiologi-
cal pH levels (6 and 8) and the change in the sensors potential was recorded 
over time. The sensor yielded a stable signal with less than 6 mV drift over a 
12 h period, providing an adequate stability for wound monitoring applica-
tion in which dressings are typically changed on daily basis. Currently, there 
is no standard test for in vitro assessment of the function of wearable sen-
sors. Thus, to test the function of the sensor on skin, the condition was mim-
icked by creating agarose hydrogels (3% w/v) with different pH values. The 
engineered hydrogels mimic the physical properties of the wounded skin. 
The sensor was placed on top of them and the output signal was recorded. 
A resistive microheater with resistance of 20Ω was designed and fabri-
cated on a flexible parylene substrate, which was lightweight and FDA-ap-
proved (Figure 2F). Electrical power was transferred to the heater using elec-
trical driver controlled by an Arduino microcontroller (LightBlue Bean, MA). 
The microcontroller could also communicate with external sources wire-
lessly, using a low-energy Bluetooth module (LightBlue Bean, MA) assem-
bled on the electrical board. For adjusting the temperature generated by 
the heater and avoiding the temperature overshoot, a commercially avail-
able flexible temperature sensor (OMEGA, CT) with a linear response and 
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Figure 2. Sensors fabrication and characterization. A–C) Optical images and design of the fabricated pH sen-
sor on PET film, carbon/PANI, and silver/silver chloride served as working electrode and reference electrode. 
D) Calibration plot of the pH sensor in range 4–10 with r2 = 0.95 and sensitivity of −50 mV pH−1. E) Transient 
response of the pH sensor over 24 h showing its long-term stability. F) Optical image of the flexible heater 
fabricated using gold electrodes on Parylene substrate. G) Calibration plot of the heater with a slope of 8 °C 
V−1. H) Transient response of the heater in a wet condition shows the response time of 5 min with applied 3 V. 
I) The temperature variation in response to cyclic application of voltage to the heater to change the platform 
temperature. J,K) Simulation for heat distribution inside the gel before and after applied electrical power, with 
consideration of the human skin showing that the generated heat influenced the hydrogel and did not impact 
on skin temperature.  
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sensitivity of 10 Ω °C−1 was assembled into the bandage next to the flexible 
heater. The feedback from the temperature sensor was used for adjusting 
the platform temperature. 
The calibration graph showed that the temperature varied linearly with 
respect to applied electrical power (Figure 2G). Additionally, transient graph 
confirmed a relatively fast response of the microheater with a time response 
of less than 5 min (Figure 2H). To evaluate the feedback control of the plat-
form for stabilizing the temperature, microheater in combination with the 
temperature sensor and electronic system was utilized. We showed the ca-
pability of the platform for dynamically switching between various tempera-
tures. The platform was programmed to switch the temperature between 30 
and 40 °C (Figure 2I). Distribution of the heat over the hydrogel onto skin was 
predicted through numerical simulation using COMSOL Multiphysics. Sim-
ulation results before and after applied electrical power confirmed precise 
control on temperature distribution within the hydrogel layer (Figure 2 J,K). 
To be able to release antibiotics on demand, we employed stimuli-re-
sponsive drug carriers that could be triggered by applying an external stim-
ulation. Temperature triggering mechanism was employed for delivery of 
antibiotics as it was safe (at temperatures lower than 42 °C) and easy-to-ap-
ply.18 PNIPAM is a biocompatible thermo-responsive material, which can go 
through hydrophilic–hydrophobic transition above its critical temperature.19 
PNIPAM’s critical temperature is around 32 °C, which might make the drug 
carriers susceptible to be self-triggered. However, PNIPAM can be grafted 
with other monomers or copolymerized to increase its critical temperature 
to ≈37 °C, reducing the possibility of undesired drug release.20 
PNIPAM particles were fabricated using microfluidic flow focusing ap-
proach in which the PNIPAM solution was introduced into the microchannel 
and was wrapped with an oil solution containing surfactant to form droplets. 
The size of the generated droplets could be tuned by adjusting the ratio be-
tween the flow rates of the two streams. The droplets were then crosslinked 
by UV irradiation. Particles with the diameter of 300 μm were fabricated, 
which were shrinking as being heated above 32 °C as shown in Figure 3A. 
This critical temperature of the PNIPAM particles makes them suitable for 
topical applications where the skin temperature is less than 37 °C. 
Details of the microparticle fabrication and drug release study can be 
found in the Experimental Section. These drug carriers were embedded into 
an alginate hydrogel layer (Figure 3D). A thin layer of rectangular alginate 
patch (2% w/v) was formed by adding solution of sodium alginate counting 
drug carriers into PDMS molds followed by spraying calcium chloride as a 
crosslinker as described elsewhere.19 
To minimize the thermal contact resistance between the microheater 
and the hydrogel layer, the hydrogel was directly cast on top of the heater. 
Chronic wounds are known for their high rate of exudate generation and 
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thus exudate management is important in the proper function of the sen-
sors and drug delivery modules. The utilized alginate-based hydrogels are 
known for high water uptake and swelling ratios and have been used in 
engineering wet wound dressings. In addition, since the sensors are in di-
rect contact with the skin, the swelling of the hydrogels is not expected to 
affect the readout. To visualize the drug release, rhodamine B was loaded 
into PNIPAM particles and the system was heated while being monitored 
under a microscope. The rhodamine B release was observed using flores-
cent images (see Figure 3E,F). In order to load drugs, lyophilized PNIPAM 
particles were soaked in cefazolin solution (10 mg mL−1) at 4 °C. Cefazolin 
Figure 3. Drug release study. A–C) Optical image of the particles in a range of temperatures. D–F) Fluores-
cence images of drug carriers embedded inside the hydrogel attached to microheater, rhodamine B was used 
for better visualization. G) Release profile of cefazolin antibiotics in different temperatures and conditions. H) 
Release rate control of cefazolin by adjusting the temperature.  
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is an effective antibiotics used against S. aureus, which is the most com-
mon bacteria in infected chronic wounds.6 After applying heat to the al-
ginate patch, the cefazolin release profile was measured over time. Data 
suggested a quick burst release, which was followed by a controlled re-
lease of the drug; about 80% of the drug was released over 1 h. The release 
from drug carriers embedded within hydrogel was prolonged in compari-
son with those freely dispersed in phosphate buffered saline (PBS) (Figure 
3G). As expected, higher temperatures led to faster release rate. To assess 
the possibility of releasing drugs in a dynamic fashion, heat was applied 
periodically (30 min on, 30 min off) and the drug release amount was de-
termined. The results suggested that after reducing the temperature, the 
antibiotic release rate was significantly reduced. By reapplying heat, the 
drug release was restored (see Figure 3H). 
A standard scratch test assay was used to evaluate the cell migration in 
presence of bacteria. It mimics the cell migration during healing of the in-
fected wound and shows the efficacy of the healing. To perform this exper-
iment, the scratch was created over a monolayer of the confluent keratino-
cytes, which were contaminated with S. aureus in advance. Three groups 
were used for this set of experiments: (1) cefazolin powder as a positive 
control, (2) alginate without antibiotic loading as a negative control, and 
(3) alginate containing cefazolin. The negative control showed the inter-
action of bacterial contamination with cell proliferation and migration ob-
served through scratch closure. The positive control enabled us to compare 
the effect of antibiotics released from the patch with free antibiotics which 
indicated that the effectiveness of the antibiotics was not affected by ther-
mal stimulation. 
The dissolved cefazolin solution was used as a control to compare its ef-
fectiveness with the stimuli-responsive release patch made of alginate con-
taining thermo-responsive drug carriers. Initial captured pictures showed a 
similar distance gap for different samples (Figure 4). When alginate/Ab or 
control samples were employed, rapid migration toward the opening area 
was observed. Moreover, the whole distance gap was covered with migrated 
cells eventually for these samples. On the other hand, the efficient migration 
was not seen when alginate patch without antibiotics was used. 
Wound dressing should not be cytotoxic or should not negatively af-
fect cellular growth. Although animal studies are the most suitable tool for 
preclinical assessment of the function of the wound care products, in vitro 
culture of human cells is also strong tool for preliminary studies. Thus, the 
engineered dressings were interfaced with the culture of human keratino-
cytes and potential toxicity of the engineered dressing was assessed. As it 
is shown in Figure 4E,F, the cell viability and total DNA content in presence 
of the antibiotic-releasing patch were similar to the control patch with via-
bility of more than 90%. 
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To evaluate the efficacy of the thermo-responsive delivery of the anti-
biotics, zone of inhibition (ZOI) and number of colony-forming units (CFU) 
tests were performed. For the ZOI test, S. aureus was cultured and added on 
the surface of an agar plate. Then, two sets of the hydrogel patches with and 
without antibiotics were placed on the bacterial culture. To prepare the hy-
drogel patch, PNIPAM particles were loaded with cefazolin and embedded 
inside the alginate hydrogel. The heater was triggered to release the drug. 
Significant ZOI (≈10 mm) around the patch loaded with antibiotics was ob-
served in comparison to the control confirming the effectiveness of the re-
leased drug in inhibiting bacterial growth (Figure 5A,B). 
Figure 4. Scratch test assay test for evaluation of cell migration: A) control sample made of cefazolin solution, 
B) alginate sample without antibiotic, and C) antibiotic patch. D) Quantitative analysis of the cell migration 
showing the gap size on the scratch wound assay. E,F) Viability of keratinocyte and total DNA content as an in-
dication of cellular proliferation in presence of the antibacterial and control samples.  
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CFU experiment was also performed to further quantify the efficacy of 
the thermo-responsive antibiotic-releasing patch. While the alginate patch 
without antibiotics as a negative control showed ≈100% viability ratio of the 
bacteria, the use of the antibiotic-loaded patch reduced their viability ra-
tio to less than 10% (Figure 5E). Moreover, the capability of the antibiotic-
eluting patch on the treatment of bacterial infection was tested on a bio-
film layer of the bacteria. Bacteria were cultured on the agar plates for 4 d 
to create a biofilm. Then, the patch with integrated microheater was placed 
on the top. Live-dead assay was used after 6 h to assess the viability of bac-
teria at the interface of the patch. We observed that bacteria had consid-
erable spread over the patch and the plate in the absence of the antibiotic 
(Figure 5C), while bacteria were killed significantly at the interface of the an-
tibiotic eluting patch (Figure 5D). 
In another experiment, a bioreactor was designed to evaluate the pH 
variation over the bacterial culture before and after activation of the smart 
patch (Figure 5F). Bacteria culture media was perfused slowly to mimic the 
in vivo condition. As shown in Figure 5G, when bacteria reached the lag 
Figure 5. In vitro evaluation of the antibacterial activity of the bandage. A,B) Diffusion test for antibacterial 
releasing hydrogel and negative control (hydrogel without antibiotics). C) Live-dead from biofilm formation 
on control patch. D) Live-dead staining from biofilm formation on antibacterial patch; live bacteria appear as 
green. E) CFU counting test for S. aureus using cefazolin. F) Schematics of in vitro model for culturing of S. au-
reus bacteria in a bioreactor monitored with pH sensor and treated with the patch loaded with antibiotic. G) 
In vitro test showing the pH variation over time followed by the activation of the heater at pH = 6.5. H) The 
integration of the electronic component, pH sensors, microheater, and drug-loaded hydrogel. The patch was 
placed on the author’s hand.   
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phase, the pH was reduced to 6.5 (the critical pH defined for the microcon-
troller in this experiment). At this pH, the bandage was automatically acti-
vated and cefazolin was released. pH raised up to 7.2 in the bioreactor with 
activated bandage whereas a stable pH was seen in the nontreated sample 
(deactivated bandage). 
The entire platform was packaged into a flexible and wearable form that 
could form conformal contact with skin. A transparent medical tape was used 
for securing it onto skin. A typical fabricated bandage with the utilized elec-
trical system is shown in Figure 5h. 
3. Conclusions 
In this work, we developed a networked closed-loop automated patch for 
monitoring and treatment of the chronic wounds. The closed-loop patch 
included sensor patch of flexible pH and temperature sensors, a hydrogel 
release patch with thermoresponsive drug-loaded carriers with integrated 
microheater, and an electronics patch. Flexible electrochemical pH sensor 
with linear response and sensitivity of −50 mV pH−1 was designed and fab-
ricated on flexible PET substrate. According to the feedback data from pH 
sensor, thermo-responsive release patch was activated for the release of the 
antibacterial drugs. Readout from the sensor and stimulation of thermo-re-
sponsive drug were achieved remotely by taking advantage of the wireless 
Bluetooth low energy module in the electronics patch. The proposed ban-
dage was characterized by in vitro bacterial study and subsequent antibiotic 
release. Additionally, scratch test assay was performed to prove the cell mi-
gration over scratch. In the proposed smart bandage, pH and temperature 
sensors and antibiotic drug serve as models of sensors and the drug, one 
could embed more sensing components, drugs, and growth factors in this 
platform for specific detection of particular healing marker and for treat-
ment of different target conditions. The assessment of clinical advantage of 
the smart and automated (feedback controlled) dressing for facilitating the 
healing process of chronic wounds and its comparison to other existing tech-
nologies and wound care products requires the use of animal models that 
represent difficult-to-treat wounds which will be carried out in the future. 
4. Experimental Section 
Materials: Chemicals including sodium alginate, agarose, CaCl2, PNIPAM, N,N′-
methylenebisacrylamide, and mineral oil were purchased from Sigma-Aldrich 
(St. Louis, MO). Irgacure 2959 (CIBA Chemicals) was used as the photoinitiator 
(PI). Cell culture reagents were obtained from Life Technologies, MA. 
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Fabrication and Characterization of pH Sensor: The pH sensors were prepared 
based on a previous work.17 Briefly, the pH sensor consisted of a working 
electrode and a solid-state Ag/AgCl reference electrode. The voltage read 
across the two electrodes corresponded to the pH level of the analyte solu-
tion. The fabrication process was conducted by laser-machining and screen-
printing. The fabrication process starts by laser cutting a single layer of tape 
(3M MagicTape) to act as a stencil mask for the screen-printing process. The 
mask was then attached to the flexible PET substrate followed by screen-
printing the carbon (MG Chemicals Graphite Conductive Coating) and sil-
ver inks (118-09, Creative Materials, Ayer, MA). After the printing process 
the mask was removed, revealing four working electrodes and one reference 
electrode. The inks were then cured in an oven set to 80 °C for 1 h. 
Using the same laser machine and settings, the perimeter of electrodes 
was removed from the PET substrate. The openings created in the PET sub-
strate allow the interface between the drug delivering hydrogel and the 
wound. Next, to prevent electrical crosstalk between the electrodes an insu-
lating layer of poly(methyl methacrylate) (PMMA; A4) was printed onto the 
conductive carbon and silver traces, which defines the active area and the 
contact pad of the sensors. The insulating layer was cured by hot plate set 
to 80 °C for 10 min followed by exposing to UV light for 5 min. 
The Ag/AgCl reference electrode was prepared by electrodepositing a 
layer of AgCl over the silver electrode. The chloridization process was per-
formed in a solution of 1.0 m NaCl and a constant current of 1 mA for 3 min 
was applied across the silver electrode and a Pt electrode. The uncovered 
area of silver electrode changes in color with the formation of silver chlo-
ride. The resulting Ag/AgCl electrode was then rinsed with deionized water 
and blow dried with nitrogen. 
The pH-sensitive membrane was prepared by dissolving 25 mg of poly-
aniline emeraldine in 10 mL dimethyl sulfoxide (DMSO), both purchased 
from Sigma-Aldrich, MA. For a complete dissolution, the mixture was placed 
in an ultrasonic bath for 2 h followed by stirring with magnetic rod for 24 
h. The solution was then remained undisturbed for 24 h to allow the undis-
solved particles to settle. The solution was decanted and filtered through a 
500 nm filter (Whatman filters) yielding a uniform dark blue solution. The 
working electrode was prepared by drop-casting 5 μL volume of the pH 
polyaniline emeraldine base solution onto the active area of the carbon 
electrodes and slowly dried at 50 °C for 2 h. The polyaniline film was then 
doped with H+ ion by placing the device in a vacuum chamber with 2 mL 
of 1 m HCl for 5 h. The HCl fumes induced by low pressure in the vacuum 
chamber introduces H+ ions into the polyaniline emeraldine based mem-
brane, which was then converted to polyaniline emeraldine salt. The elec-
trodes were then rinsed with DI and dried with nitrogen. 
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The solid-state reference membrane was made by mixing 1:1 ratio of 
fine KCl powdered (Sigma-Aldrich) with UV-curable adhesive (Henkel Loctite 
3105). The blend was thoroughly mixed using ultrasound, forming a uniform 
slurry. The slurry was then cast onto the Ag/AgCl electrode and cured un-
der UV light for 10 min. During the UV exposure, the working electrode was 
protected with an aluminum foil cover. The measurements were conducted 
in different pH buffer solutions ranging from pH of 4 to pH of 10. The buff-
ered solutions were purchased from Nova Analytics (Pinnacle pH Buffers). 
The performance of the fabricated sensors was assessed by potentiomet-
ric measurements across the pH-sensitive working electrode Ag/AgCl ref-
erence electrode with using a BASI potentiostat. 
Fabrication of Microheater and Temperature Sensor: Microheater was de-
signed and prepared based on a previous work.21 For fabrication of the mi-
croheater, first a glass wafer was covered by 25 μm parylene as a substrate 
using parylene coater (PDS2010) with 20 g of dimer. The wavy geometry of 
the microheater was designed in CAD software to be used as a mask. Ad-
hesive mask was prepared with a laser cutter (Versa, VLS2.40) (power 40%, 
speed 20%) and attached to the substrate. A 20 nm chromium as an adhe-
sive layer and a 200 nm gold layer were sputtered subsequently. Then, adhe-
sive mask was peeled off and left behind a wavy pattern with 20 Ω resistance. 
For the characterization of the microheater using electronic driver, con-
stant voltage was applied using an electronic driver board. 
Particle Characterization and Drug Loading: A microfluidic coflowing device 
was used to fabricate PNIPAM microparticles. In this system, a 10% (w/v) 
PNIPAM, 0.3% (w/v) N,N-methylene-bis-acrylamide (BIS), and 0.5% (w/v) of 
PI solution in water was injected through the central nozzle using a syringe 
pump. A solution of mineral oil containing 20% (v/v) of Span80 as surfactant 
was injected using another syringe pump to form a sheath around the cen-
tral stream. The core flow was broken into spherical droplets and the drop-
let size could be tuned by changing the flow rates using two syringe pumps. 
Once the microdroplets have been formed, they are collected in a Petri dish 
and are polymerized by UV-light for 3 min in the temperature around 4 °C 
and the UV intensity of 850 mW and the distance between the tip of the fi-
ber optic and the Petri dish is set to 6 cm. Subsequently, the microhydro-
gels were washed with ethanol and distilled water several times to remove 
the environmental oil and then were verified under microscope visually, after 
that the particles were freeze-dried and stored in 4 °C for future experiments. 
The freeze-dried microcarriers were immersed in distilled water with 
drug (concentration) and they swell promptly to their original size while 
absorbing the drug. When temperature reached above lower critical solu-
tion temperature (LCST) phase transition occurred and the particles change 
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from hydrophilic polymer to a hydrophobic polymer, this alteration led to 
an ejection of water. This drying and swelling behavior was a reversible pro-
cess that did not cause morphological damage. 
Drug Release with Integrated Heaters: Alginate hydrogel with embedded 
drug microcarriers was attached on the surface of the microheater while 200 
μL PBS was added into the plate and electrical voltage was applied to gen-
erate heat. The drug released into the solution was evaluated using plate 
reader. 
Bacterial Study: A single colony of S. aureus was inoculated into 10 mL liq-
uid broth (LB) culture medium overnight. For preparation of the fresh bacte-
ria solution, 100 μL of this sample were added to a 10 mL LB and incubated 
at 36 °C, 200 rpm overnight. After being incubated and reaching OD600 of 
≈0.4, 1 mL of the fresh bacteria was spread on an LB agar plate, the strain 
enters the exponential period of growth and the culture broth was diluted. 
Bacteria with the concentration of ≈1 × 105 cells mL−1 were cultured for ZOI 
and CFU counting experiments. To investigate the application of device on 
bacteria, the device was placed on the surface of cultured bacteria, and dif-
ferent electrical voltages were applied to the conductive pattern to generate 
heat. A blank control sample without antibiotics was prepared for compar-
ison. All the plates were incubated at 37 °C for an appropriate time. Finally, 
the plates were taken out of the incubator and the ZOI and number of re-
maining CFUs were calculated. 
Scratch Wound Healing Assay and Cell Studies: Adult Normal Human Epi-
dermal Keratinocytes purchased from ATCC were cultured in a DMEM-based 
medium containing 10% FBS and 1% penicillin/ streptomycin. For cytotoxic-
ity assessment, circular samples (1 cm in diameter) were prepared and placed 
at the bottom of 24-well polystyrene plates. Then, cells were resuspended 
in culture media at the concentration of 1 × 107 cells mL−1 and 5000 cells 
were seeded on the samples. The samples were incubated for 1 h to allow 
the cells to attach and then 300 μL of culture medium was added to each 
well. Cellular metabolic activity was measured using PrestoBlue assay on 
days 1, 3, and 7 as per manufacturer’s protocol. The fluorescent intensity of 
the assay was measured using a BioTek UV/vis Synergy 2 microplate reader. 
Keratinocytes (1 × 105) were seeded and cultured in a six-well plate and 
kept overnight to make a confluent monolayer overnight. The 1 mm wide 
gap scratch was then created onto the monolayer with a 200 μL pipette tip, 
and floating cells were removed by twice washing with PBS. After the line 
scratches, 2 mL of DMEM was added for each group. To detect the efficacy 
of treatments on cell migration, samples were continually imaged for 0, 8, 
24, and 48 h. Images of the monolayer were taken by a microscope and cell 
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migration activity was evaluated as the migration distance from the edges 
of the scratch toward the center of it using Image J software (NIH, Bethesda, 
MD, USA). For each well, ten images were taken and selected randomly. Ex-
periments were done independently in triplicate.   
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